TX-SOFTSERVE
1.2.2024 16:23:26 CET | Business Wire | Press release
SoftServe, a premier IT consulting and digital services provider, today announced its newest advisory service: DevIQ. In partnership with process intelligence platform Bloomfilter, SoftServe’s DevIQ Advisory Service empowers organizations to align their software development processes with strategic business objectives, ensuring development efforts are productive, streamlined, and effective.
DevIQ advisory service brings observability, predictability, and efficiency to companies using Agile frameworks in their software development life cycle (SDLC). Services come with a guided road map for saving up to 20% in software development costs by combining the power of process mining with tangible results in just 10 days.
“DevIQ enables users to gain invaluable insights into the inner workings of software development, offering an X-ray view that reveals the intricacies of your development process,” said Chuck Ros, SoftServe’s Industry Success Leader for High Tech and Emerging Markets. "Instead of just instructing developers to ‘do more, faster,’ we uncover hidden inefficiencies, enabling our customers to see them and their financial impact through a ‘single pane of glass.’ Unbiased metrics measurement and remediations provided through our DevIQ advisory leads to higher efficiency and predictability in the SDLC. This is a game changer for our clients – creating the opportunity for synced productive milestone conversations from the project level to the executive level.”
In addition to process mining intelligence, other key highlights of the new advisory service include:
- Observability: DevIQ brings observability in software projects, specifically beneficial for businesses using Jira Cloud or GitHub in their SDLC, ensuring seamless alignment across the entire company and fostering a unified understanding of priorities and execution status.
- Predictability: With a focus on predictability, DevIQ ensures software projects are delivered on time, within budget, and with superior quality.
- Efficiency and Innovation: DevIQ enhances workflows and ensures each software development phase operates efficiently, which accelerates project timelines, optimizes resource use, and propels organizations toward innovation goals.
SoftServe's DevIQ advisory service, backed by our extensive experience with companies utilizing SDLC processes, has consistently driven impactful results. Our contributions include reducing time-to-market through agile transformation and enhancing technology delivery capabilities. These improvements can be realized in any company that develops software for their internal use or customer base. Any company in any domain that builds software can benefit from DevIQ.
To learn more about SoftServe's DevIQ Advisory Service, please visit this webpage.
ABOUT SOFTSERVE
SoftServe is a premier IT consulting and digital services provider. We expand the horizons of new technologies to solve today's complex business challenges and achieve meaningful outcomes for our clients. Our boundless curiosity drives us to explore and reimagine the art of the possible. Clients confidently rely on SoftServe to architect and execute mature and innovative capabilities, such as digital engineering, data and analytics, cloud, and AI/ML.
Our global reputation is gained from more than 30 years of experience delivering superior digital solutions at exceptional speed by top-tier engineering talent to enterprise industries, including high tech, financial services, healthcare, life sciences, retail, energy, and manufacturing. Visit our website, blog, LinkedIn, Facebook, and X (Twitter) pages for more information.
ABOUT BLOOMFILTER
Bloomfilter is a process intelligence platform for software development, designed to measure and improve the software development life cycle. The platform helps organizations develop a shared understanding of what the product team is building, when it will be delivered, and how much it costs. Visit www.thebloomfilter.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201938455/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
Tigo Energy and Google Cloud Pair AI-Powered Tools for Solar Installers and Utilities12.11.2026 15:00:00 CET | Press release
The collaboration combines Tigo software with Google’s Gemini models on Google Cloud to help automate installer and utility operations for distributed energy portfolios. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a collaboration with Google Cloud to develop AI-enabled operational workflows for solar installers and distributed energy portfolios. By making core Tigo data and software products available through Google Cloud, Tigo aims to deliver faster deployment, simplified data integration, and additional insights with Gemini. The resulting workflows will help installers, asset managers, and energy operators more easily identify issues, prioritize actions, and automate routine operational tasks across growing fleets of distributed energy systems. As solar and storage portfolios expand, energy businesses are increasingly responsible for managing more sites, more system data, and more custo
Patsnap Releases State of Pharma Intelligence 2026 Report, Reveals Pharma's Cautious Embrace of AI in Decision-Making12.11.2026 15:00:00 CET | Press release
A new survey of 130 senior life sciences leaders on AI in pharma R&D and competitive intelligence finds that 92% can name a recent R&D, portfolio, or partnership decision where AI changed the outcome. Patsnap, the AI-native innovation intelligence company for IP and R&D teams, today released "State of Pharma Intelligence 2026: The Confidence to Act", a benchmark report on how pharma teams use and trust AI in R&D, competitive intelligence and business development decisions. The report draws on responses from 130 senior leaders at Director level or above across the United States, the United Kingdom, Germany, Switzerland, and France, spanning drug developers, CDMOs/CMOs, CROs, and consulting and professional services firms. The survey was fielded in August 2026 in partnership with NewtonX. Patsnap commissioned the research to understand how AI is influencing decisions across pharma R&D and business development, what builds confidence in its output, and where intelligence workflows fall sh
REPLY: the Board of Directors Approves the Quarterly Financial Report as of 30 September 202612.11.2026 14:41:00 CET | Press release
All economic indicators have substantially improved:Consolidated turnover of €1,987.9 million (1,819.8 as at 30 September 2025)EBITDA of €354.9 million (335.5 as at 30 September 2025)EBIT of €286.7 million (281.0 as at 30 September 2025)Pre-tax profit of €291.6 million (268.1 as at 30 September 2025)Positive Net Financial Position of €397.0 million. Today, the Board of Directors of Reply [EXM, STAR: REY] approved the results as at 30 September 2026. The Group's consolidated turnover in the first nine months of the year reached €1,987.9 million, an increase of 9.2% compared to €1,819.8 million recorded on 30 September 2025. The indicators for the period are positive. Consolidated EBITDA was €354.9 million, equal to 17.9% of the consolidated revenues. As of September 2025 EBITDA was €335.5 million. EBIT, from January to September, reached €286.7 million, equal to 14.4% of the consolidated revenues. The corresponding 2025 figure was €281.0 million. Pre-tax profit, from January to Septembe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom